Literature DB >> 23121536

Management of myocardial ischemia. Is ranolazine needed? For all or some patients with myocardial ischemia?

Giuseppe Cocco.   

Abstract

This editorial refers to 'Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal' by U Thadani also published in this issue.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23121536     DOI： 10.1517/14656566.2012.741592

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


  2 in total

Review 1.  Advancements in pharmacotherapy for angina.

Authors:  Ankur Jain; Islam Y Elgendy; Mohammad Al-Ani; Nayan Agarwal; Carl J Pepine
Journal:  Expert Opin Pharmacother       Date:  2017-03-15       Impact factor: 3.889

2.  Ranolazine reduces patient-reported angina severity and frequency and improves quality of life in selected patients with chronic angina.

Authors:  Joseph B Muhlestein; Sharon Grehan
Journal:  Drugs R D       Date:  2013-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.